title: Clinical relevance of immunocytochemical detection of multidrug-resistance-associated P-glycoprotein in hematologic malignancies.
abstract: P-glycoprotein (P-170) is the phenotypic marker of tumoral cells that show the phenomenon of multidrug resistance (MDR). Using an immunocytochemical approach, we employed the monoclonal antibody C219 (which recognizes an epitope of such a glycoprotein) to evaluate in cytologic samples the expression of P-170 on neoplastic cells from 52 patients affected by different hematologic malignancies and its eventual correlation to clinical outcome. Longitudinal studies were also performed in 14 patients. Results obtained demonstrated that a) the so-called "MDR phenotype" may be heterogeneously represented (from less than 1 to 100% of positive cells) in hemopoietic tumors at diagnosis (without exposure to pharmacologic agents), as well as during the course of the disease, although a more substantial presence of P-170 occurred in treated patients. There was no correlation between neoplastic kinetic activity (such as expression of Ki 67 recognized nuclear proliferation-associated antigen) and P-170-positive cells. b) Percentage of positive cells as well as intensity of staining seemed to be important in determining MDR; in general, there was a strong correlation between expression of P-170 in more than 20% of neoplastic cells and a lack of response to chemotherapy. However, some false-positive and false-negative cases were observed. c) The detection of scattered P-170-positive cells may predict a pharmacologic selection of intrinsic or mutant-resistant clones.
authors.affiliation: Divisione di Ematologia, Ospedale Generale Regionale Casa Sollievo della Sofferenza, Foggia.
authors.forename: P
authors.initials: P
authors.lastname: Musto
authors.forename: N
authors.initials: N
authors.lastname: Cascavilla
authors.forename: N
authors.initials: N
authors.lastname: Di Renzo
authors.forename: S
authors.initials: S
authors.lastname: Ladogana
authors.forename: A
authors.initials: A
authors.lastname: La Sala
authors.forename: L
authors.initials: L
authors.lastname: Melillo
authors.forename: M
authors.initials: M
authors.lastname: Nobile
authors.forename: R
authors.initials: R
authors.lastname: Matera
authors.forename: G
authors.initials: G
authors.lastname: Lombardi
authors.forename: M
authors.initials: M
authors.lastname: Carotenuto
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents / Q000378:metabolism*; D004351:Drug Resistance; D006801:Humans; D007150:Immunohistochemistry; D007938:Leukemia / Q000378:metabolism*; D008137:Longitudinal Studies; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D010641:Phenotype; D011237:Predictive Value of Tests
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D008562:Membrane Glycoproteins